Evidence map›Paper›PMID 41326404›Full record

ArticleNature communications2025

Interferon dependent immune memory during HSV-1 neuronal latency via increased H3K9me3 and restriction by ATRX.

Abigail L Whitford, Gaelle Auguste, Alison K Francois, David J Picketts, Chris Boutell, Clint L Miller, Sarah Dremel, Anna R Cliffe

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abigail L WhitfordDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA.
Gaelle AugusteDepartment of Genome Sciences, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0003-4900-6959
Alison K FrancoisDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0003-2854-0546
David J PickettsRegenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.ORCID 0000-0002-9227-2016
Chris BoutellMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.ORCID 0000-0002-2970-7785
Clint L MillerDepartment of Genome Sciences, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0003-4276-3607
Sarah DremelDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0003-0968-3090
Anna R CliffeDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, USA. cliffe@virginia.edu.ORCID 0000-0003-1136-5171

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
Multimodal genetic regulatory architecture of coronary artery diseaseR01HL148239 · NHLBI · UNIVERSITY OF VIRGINIA · PI Clint L Miller · 2019 to 2026
$4.2M
Functional genomics investigation of pleiotropic vascular disease lociR01HL164577 · NHLBI · UNIVERSITY OF VIRGINIA · PI MILLER, CLINT L · 2022 to 2025
$2.3M
The role of ATRX in both promoting the establishment of HSV latency and restricting reactivationR01NS135166 · NINDS · UNIVERSITY OF VIRGINIA · PI Anna Ruth Cliffe · 2024 to 2026
$1.6M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) T32AI007046Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT165994NHLBI NIH HHS R01 HL148239NHLBI NIH HHS R01 HL164577NIAID NIH HHS T32 AI007046NINDS NIH HHS R01 NS135166RCUK | MRC | Medical Research Foundation MC_UU_00034/2U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS135166
6 · The paper itself

Abstract

Herpes simplex virus-1 (HSV-1) establishes a latent infection in neurons, periodically reactivating to cause disease. Neuronal conditions, including immune signaling, during initial HSV-1 infection, impact later reactivation. Type I interferon (IFNα) exposure during initial infection results in promyelocytic leukemia nuclear-body (PML-NB) formation and subsequent restriction of reactivation, via mechanisms that were unknown. Here we find that PML-NB formation results in the recruitment of histone chaperones to the viral genome and increased enrichment of the repressive heterochromatin mark, histone H3 lysine 9 tri-methylation (H3K9me3), and its reader, ATRX (alpha-thalassemia/mental retardation, X-linked). ATRX is highly abundant in neurons and prevents reactivation from H3K9me3-bound latent genomes by remaining associated with viral chromatin. Therefore, we demonstrate how immune signaling during initial infection results in an epigenetic memory on HSV-1 genomes and identify ATRX as a neuronal restriction factor against HSV-1 reactivation, elucidating a new potential target for inhibiting HSV-1 reactivation and subsequent human disease.

Indexed as

Herpes SimplexHerpesvirus 1, HumanHistonesImmunologic MemoryNeuronsVirus LatencyX-linked Nuclear ProteinAnimalsEpigenesis, GeneticGenome, ViralHumansInterferon-alphaMicePromyelocytic Leukemia ProteinVirus ActivationATRX protein, humanHistonesInterferon-alphaPromyelocytic Leukemia ProteinX-linked Nuclear Protein

Identifiers

PMID41326404
PMCPMC12764766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.